{"id":"NCT00618774","sponsor":"Boehringer Ingelheim","briefTitle":"An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose Combination","officialTitle":"An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose Combination","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-01","primaryCompletion":"2009-10","completion":null,"firstPosted":"2008-02-20","resultsPosted":"2010-03-03","lastUpdate":"2014-06-27"},"enrollment":259,"design":{"allocation":null,"model":"PARALLEL","masking":null,"primaryPurpose":"TREATMENT"},"conditions":["Hypertension"],"interventions":[{"type":"DRUG","name":"telmisartan40/amlodipine5","otherNames":[]},{"type":"DRUG","name":"telmisartan80/amlodipine5","otherNames":[]}],"arms":[],"summary":"To assess the long term safety and efficacy of telmisartan plus amlodipine FDC in patients with essential hypertension who failed to control their BP with either monotherapy","primaryOutcome":{"measure":"Percentage of Participants Who Experienced Adverse Events","timeFrame":"52 weeks","effectByArm":[{"arm":"Telmisartan 40 mg Plus Amlodipine 5 mg Fixed-dose Combination","deltaMin":77.3,"sd":null},{"arm":"Telmisartan 80 mg Plus Amlodipine 5 mg Fixed-dose Combination","deltaMin":77.1,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":2},"locations":{"siteCount":7,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":211},"commonTop":["Nasopharyngitis","Back pain","Dental caries"]}}